MAY 30, 2014 09:00 AM PDT
Panel Discussion: Vaginitis/vaginosis: Diagnosis and workup using conventional and molecular tests. Dr's Bowman and Wang
Presented at the Clinical Diagnostics and Research Virtual Event
78 44 2009

Speakers:
  • Dr. Bowman is Medical Director, Enzo Clinical Laboratories Dr. Wang is Chief of Microbiology and Molecular Diagnostics Westchester Medical Center, New York Medical College
    Biography
      Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a surgery intern and then anatomic and clinical pathology resident. She worked as an emergency room physician during training and has always had a clinical perspective in her practices. She has worked in California, Maine, Massachusetts, New York and Australia as an anatomic and clinical pathologist and laboratory medical director in small, mid-sized, tertiary and academic  medical centers. She is currently Medical Director at Enzo Clinical Laboratories, a commercial reference laboratory and bioscience company in the NY metropolitan area, and in that capacity collaborates with the development and integration of molecular services into clinical testing.  She has been active in national laboratory organizations, especially the College of American Pathologists, where she was chair of the Point of Care Testing Resource Committee. In that capacity she guided the introduction and was the senior editor of a web-based POCT toolkit as a resource for laboratory director leadership in POCT.  She has also written and edited multiple educational pieces for the laboratory community as part of the CAP Excel Survey program and in 2012 she was awarded a Life Time Achievement Award by the CAP. She has spoken at AACC and CAP meetings and currently serves on several CLSI document development committees. She is currently chair of an International Federation of Clinical Chemistry POCT task force work group addressing the use of glucose  meters in critical care patients.  Her professional commitment has always been to integrate and translate pathology and laboratory medicine services into effective clinical care. She has dedicated her efforts in POCT as part of that vision to collaborate with all stakeholders and involve laboratory services as part of the continuum of care. She enjoys evaluating technology and integrating it into laboratory services.
       
      Dr. Wang is the Chief of Laboratory Services for Microbiology, Virology and Molecular Diagnostics in the Department of Pathology at Westchester Medical Center. He is double board-certified in clinical microbiology and molecular diagnostics by the American Board of Medical Microbiology and American Board of Clinical Chemistry. Dr. Wang received his education and training in clinical medicine and epidemiology in China. He earned his Ph.D. degree in medical microbiology from University of Amsterdam, the Netherlands, and completed an accredited fellowship in clinical & public health microbiology at University of California, Los Angeles Medical Center.  At Westchester Medical Center, Dr. Wang joins the Pathology Department and provides mainly clinical diagnostic services in microbiology and molecular diagnostics. He developed several home-brew molecular tests for in vitro diagnosis of infectious diseases. Apart from his clinical work, he has been serving as principal investigator of multiple research projects. The areas of his interest include laboratory diagnosis of infectious diseases, especially molecular detection and mechanism studies of emerging tick-borne diseases and antimicrobial resistance. He has published more than 50 peer-reviewed papers on these subjects. 
       

    Abstract:

    Vaginitis and vaginosis, including Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC), and Trichomoniasis (TV), are extremely common conditions, consuming many healthcare resources and having significant potential adverse consequences for women. Traditional diagnosis has relied on clinical signs and symptoms and a number of conventional diagnostic tests. The presentation of vaginitis and vaginosis is not always typical, and the usual diagnostic tests are not always straight forward, reproducible, or sensitive. Newer molecular techniques may be more sensitive and revealing about the conditions. They have also helped to re-shape our understanding about BV, VVC, and TV, but they are more complex and expensive. This presentation will discuss the spectrum of conventional and molecular tests currently available for BV, VVC, and TV and compare tests performance and utility in light of clinical indications.

    Learner Objectives:

    Attendee will be able to:

    1. Describe the pertinent clinical characteristics of BV, VVC, and TV.

    2. List the classic or conventional diagnostic criteria for BV, VVC, TV.

    3. Identify the most common conventional tests for BV, VVC, TV.

    4. List current and upcoming molecular tests for identifying BV, VVC, and TV.

    5. Compare the advantages and disadvantages of conventional versus molecular tests for BV, VVC, and TV.

    6.Distinguish when conventional tests or molecular tests might be indicated for BV, VVC, and TV.


    Show Resources
    Loading Comments...